Information Links
Men's health news

First topical treatment for premature ejaculation now available on prescription
Fortacin is the first topical treatment approved for...

GPs should no longer prescribe 18 'low value' treatments, NHS England rules
NHS England believes cutting access to the treatments,...

Sildenafil to be available over the counter
Men with erectile dysfunction (ED) will be able to...

HIV drug first to be approved in UK for pre-exposure prophylaxis
Truvada (emtricitabine/tenofovir) is indicated in combination...

Aviptadil/phentolamine launched as combination treatment for erectile dysfunction
Invicorp (aviptadil/phentolamine) is a new combination...

Women-only constipation treatment now licensed in men
Prescribers can now consider the 5HT4 agonist prucalopride...

Xiapex now indicated in Peyronie's disease
Xiapex (collagenase) is licensed to treat Peyronie's...

Prescribing restrictions for generic sildenafil removed
The Department of Health has removed restrictions requiring...

Prolia approved for male osteoporosis
Prolia (denosumab) can now be prescribed in men with...

Vitaros: a new topical treatment for erectile dysfunction
Vitaros, a topical cream formulation of alprostadil,...

Spedra launch provides new option for erectile dysfunction
Spedra (avanafil), a new PDE5 inhibitor, has been launched...

Vesomni: combination tablet for urinary storage symptoms associated with BPH
Vesomni is a fixed-dose, modified-release combination...

Priligy: first licensed treatment for premature ejaculation
Priligy (dapoxetine) is the first licensed treatment...

Xtandi: oral anti-androgen for metastatic prostate cancer
Xtandi (enzalutamide) is an anti-androgen licensed...

Nipatra: chewable sildenafil tablet for erectile dysfunction
Amdipharm Mercury has launched a chewable tablet formulation...

News in brief - August 2013
Other new launches, licence changes and updates relevant...

Zytiga approved for use before chemotherapy
The licence for Zytiga (abiraterone) has been extended...

Cialis: first PDE5 inhibitor licensed for benign prostatic hyperplasia
Tadalafil (Cialis) has been approved for the treatment...

NICE approval for denosumab in cancer
The osteoclast-targeting antibody denosumab has been...
MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.